hotspot
Previous article:
After affirmative action ruling, medical educators look to 'holistic review'
Next article: Prime Medicine, Myeloid Therapeutics clash over genome
Next article: Prime Medicine, Myeloid Therapeutics clash over genome
knowledge
entertainment
-
SEC charges former device maker CEO with $41 million fraud
2025-09-29 20:22 -
Readout LOUD podcast: Merger Mondays, Ozempic panic
2025-09-29 20:07 -
European regulators recommend Amylyx's ALS drug be rejected
2025-09-29 20:04 -
STAT Readout Newsletter: Today in biotech, life science news
2025-09-29 19:42 -
UnitedHealth’s Q3 profit jumps as medical costs rise more slowly
2025-09-29 19:33 -
Akero's treatment for NASH falls short in cirrhosis study
2025-09-29 19:12